Cytori Therapeutics PE Ratio (TTM)
Cytori Therapeutics PE Ratio (TTM) Chart
Cytori Therapeutics Historical PE Ratio (TTM) Data
|Data for this Date Range|
|Dec. 30, 2004||45.78|
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About Price to Earnings Ratio
The price to earnings ratio (PE Ratio) is the measure of the share price relative to the annual net income earned by the firm per share. PE ratio shows current investor demand for a company share. A high PE ratio generally indicates increased demand because investors anticipate earnings growth in the future. The PE ratio has units of years, which can be interpreted as the number of years of earnings to pay back purchase price.
PE ratio is often referred to as the "multiple" because it demonstrates how much an investor is willing to pay for one dollar of earnings. PE Ratios are sometimes calculated using estimations of next year's earnings per share in the denominator. When this happens, it is usually noted.
For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
CYTX PE Ratio (TTM) Benchmarks
|Tandem Diabetes Care||--|
CYTX PE Ratio (TTM) Excel Add-In Codes
- Metric Code: pe_ratio
- Latest data point: =YCP("CYTX", "pe_ratio")
- Last 5 data points: =YCS("CYTX", "pe_ratio", -4)
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
MT Newswires 03/28 14:31 ET
Globe Newswire 03/28 12:00 ET
MT Newswires 03/09 09:20 ET
SA Breaking News 03/09 08:12 ET
MT Newswires 03/08 17:52 ET
SA Breaking News 03/08 16:37 ET
MT Newswires 03/08 16:33 ET
Globe Newswire 03/08 16:25 ET
Globe Newswire 02/22 16:15 ET
Globe Newswire 02/15 08:00 ET